AC Immune to receive milestone payment for Anti-Tau Antibody moving into Phase 1 trial for Alzheimer's disease | AC Immune SA

AC Immune to receive milestone payment for Anti-Tau Antibody moving into Phase 1 trial for Alzheimer's disease

Jul 7, 2016

English 153.3 KB

Français 157.9 KB

Deutsch 156.5 KB

AC Immune to receive second milestone payment of CHF14 million under collaboration agreement with Genentech